Park C-W, Han C-T, Sakaguchi Y, Lee J, Youn H-Y. The safety evaluation of FM101, an A3 adenosine receptor modulator, in rat, for developing as therapeutics of glaucoma and hepatitis. EXCLI J. [Internet]. 2020 Feb. 12 [cited 2024 Apr. 19];19:187-200. Available from: https://www.excli.de/index.php/excli/article/view/1791